Mutational signature of extracranial meningioma metastases and their respective primary tumors

Berghoff AS, Hielscher T, Ricken G, Furtner J, Schrimpf D, Widhalm G, Rajky U, Marosi C, Hainfellner JA, von Deimling A et al (2022) Prognostic impact of genetic alterations and methylation classes in meningioma. Brain Pathol 32:e12970. https://doi.org/10.1111/bpa.12970

Article  CAS  Google Scholar 

Bi WL, Abedalthagafi M, Horowitz P, Agarwalla PK, Mei Y, Aizer AA, Brewster R, Dunn GP, Al-Mefty O, Alexander BM et al (2016) Genomic landscape of intracranial meningiomas. J Neurosurg 125:525–535. https://doi.org/10.3171/2015.6.jns15591

Article  CAS  Google Scholar 

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y et al (2017) Genomic landscape of high-grade meningiomas. Doi, NPJ Genom Med. https://doi.org/10.1038/s41525-017-0014-7

Book  Google Scholar 

Bi WL, Zhang M, Wu WW, Mei Y, Dunn IF (2016) Meningioma genomics: diagnostic, prognostic, and therapeutic applications. Front Surg 3:40. https://doi.org/10.3389/fsurg.2016.00040

Article  Google Scholar 

Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C, Schichor C (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469–477. https://doi.org/10.1007/s11060-019-03312-x

Article  CAS  Google Scholar 

Biczok A, Kraus T, Suchorska B, Terpolilli NA, Thorsteinsdottir J, Giese A, Tonn JC, Schichor C (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neurooncol 139:671–678. https://doi.org/10.1007/s11060-018-2912-7

Article  CAS  Google Scholar 

Birzu C, Peyre M, Sahm F (2020) Molecular alterations in meningioma: prognostic and therapeutic perspectives. Curr Opin Oncol 32:613–622. https://doi.org/10.1097/CCO.0000000000000687

Article  CAS  Google Scholar 

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000

Article  CAS  Google Scholar 

Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, Krausz T, Pass HI, Yang H, Gaudino G (2020) Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov 10:1103–1120. https://doi.org/10.1158/2159-8290.CD-19-1220

Article  CAS  Google Scholar 

Chaichana KL, Jallo GI, McGirt MJ, Goldstein IM, Tobias ME, Kothbauer KF (2008) Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 63:55–61. https://doi.org/10.1227/01.Neu.0000335070.37943.09

Article  Google Scholar 

Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129:337–345. https://doi.org/10.1007/s11060-016-2181-2

Article  Google Scholar 

Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, Chen WC, Viner JA, Aghi MK, Theodosopoulos PV et al (2019) Meningioma metastases: incidence and proposed screening paradigm. J Neurosurg 132:1447–1455. https://doi.org/10.3171/2019.1.JNS181771

Article  Google Scholar 

Du Y, Lu T, Huang S, Ren F, Cui G, Chen J (2018) Somatic mutation landscape of a meningioma and its pulmonary metastasis. Cancer Commun (Lond) 38:16. https://doi.org/10.1186/s40880-018-0291-2

Article  Google Scholar 

Ismail IH, Davidson R, Gagne JP, Xu ZZ, Poirier GG, Hendzel MJ (2014) Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res 74:4282–4294. https://doi.org/10.1158/0008-5472.CAN-13-3109

Article  CAS  Google Scholar 

Kessler RA, Garzon-Muvdi T, Yang W, Weingart J, Olivi A, Huang J, Brem H, Lim M (2017) Metastatic atypical and anaplastic meningioma: a case series and review of the literature. World Neurosurg 101:47–56. https://doi.org/10.1016/j.wneu.2017.01.070

Article  Google Scholar 

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  Google Scholar 

Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, Sill M, Euskirchen P, Blume C, Patel A et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39:3839–3852. https://doi.org/10.1200/JCO.21.00784

Article  CAS  Google Scholar 

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200

Article  Google Scholar 

Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M et al (2018) Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol 36:2863–2871. https://doi.org/10.1200/JCO.2018.78.5204

Article  CAS  Google Scholar 

Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d’Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A et al (2013) Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 92:974–980. https://doi.org/10.1016/j.ajhg.2013.04.012

Article  CAS  Google Scholar 

Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515–521. https://doi.org/10.1038/363515a0

Article  CAS  Google Scholar 

Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP et al (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180–184. https://doi.org/10.1038/ng0294-180

Article  CAS  Google Scholar 

Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T et al (2016) PTERT promoter mutations and risk of recurrence in Meningioma. J National Cancer Inst. https://doi.org/10.1093/jnci/djv377

Article  Google Scholar 

Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682–694. https://doi.org/10.1016/S1470-2045(17)30155-9

Article  CAS  Google Scholar 

Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol 19:535–545. https://doi.org/10.1093/neuonc/now235

Article  CAS  Google Scholar 

Shankar GM, Santagata S (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol 19:1447–1456. https://doi.org/10.1093/neuonc/nox094

Article  CAS  Google Scholar 

Stalhammar G, See TRO, Phillips S, Seregard S, Grossniklaus HE (2019) Digital image analysis of BAP-1 accurately predicts uveal melanoma metastasis. Transl Vis Sci Technol 8:11. https://doi.org/10.1167/tvst.8.3.11

Article  Google Scholar 

Szalai E, Wells JR, Ward L, Grossniklaus HE (2018) Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis. Ophthalmology 125:203–209. https://doi.org/10.1016/j.ophtha.2017.07.018

Article  Google Scholar 

Tang M, Wei H, Han L, Deng J, Wang Y, Yang M, Tang Y, Guo G, Zhou L, Tong A (2017) Whole-genome sequencing identifies new genetic alterations in meningiomas. Oncotarget 8:17070–17080. https://doi.org/10.18632/oncotarget.15043

Article  Google Scholar 

Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022–1025. https://doi.org/10.1038/ng.912

Article  CAS  Google Scholar 

Unterrainer M, Ilhan H, Vettermann F, Cyran CC, Tonn JC, Niyazi M, Bartenstein P, Albert NL (2019) Whole-body staging of metastatic atypical meningioma using 68Ga-DOTATATE PET/CT. Clin Nucl Med 44:227–228. https://doi.org/10.1097/RLU.0000000000002422

Article  Google Scholar 

Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS et al (2020) Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:171. https://doi.org/10.1186/s40478-020-01040-2

Article  CAS  Google Scholar 

Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–1117. https://doi.org/10.1038/nature09515

Article  CAS  Google Scholar 

Yuzawa S, Nishihara H, Tanaka S (2016) Genetic landscape of meningioma. Brain Tumor Pathol 33:237–247. https://doi.org/10.1007/s10014-016-0271-7

Article  CAS  Google Scholar 

Zadeh G, Karimi S, Aldape KD (2016) PIK3CA mutations in meningioma. Neuro Oncol 18:603–604. https://doi.org/10.1093/neuonc/now029

Article  Google Scholar 

留言 (0)

沒有登入
gif